This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases.

 
Web www.patentalert.com

< Substituted gamma lactams as therapeutic agents

> Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect

~ 00433